September 2022

Endotronix 2

Endotronix Celebrates 400th Implant of Cordella™ Pulmonary Artery Pressure Sensor for Proactive, Remote Heart Failure Management

Endotronix, Latest News / By

Lisle, Ilinois, USA.  30 September 2022.  Seroba portfolio company, Endotronix, Inc., a privately-held digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), today announced implantation of the 400th Cordella™ Pulmonary Artery (PA) Pressure Sensor.  The milestone includes successful implants across the company’s completed European trials, SIRONA First-in-Human and SIRONA …

Endotronix Celebrates 400th Implant of Cordella™ Pulmonary Artery Pressure Sensor for Proactive, Remote Heart Failure Management Read More »

Storm Round

STORM Therapeutics Appoints Dr. Jerry McMahon as Chief Executive Officer.

Latest News, Storm Therapeutics / By

Cambridge, England, 7 September 2022.  Seroba portfolio company, STORM Therapeutics Ltd. (STORM), the biotechnology company discovering and developing novel small molecule therapies targeting RNA modification enzymes for oncology and other diseases, today announced the appointment of Dr. Gerald (Jerry) McMahon as President and Chief Executive Officer and Board Director. Dr. McMahon brings with him more …

STORM Therapeutics Appoints Dr. Jerry McMahon as Chief Executive Officer. Read More »

We use cookies and analytics to improve your online experience and to help us to understand where our audience is and how they reach us, as well as to understand what topics and site features are of greatest interest.  To find out more, please read our Privacy Policy. By clicking on the Accept button, you consent to our use of cookies and browsing analytics.

Scroll to Top